ISIN | CH0272292837 |
---|---|
Valor Number | 27229283 |
Bloomberg Global ID | |
Fund Name | JSS Sustainable Equity - Switzerland I CHF dist |
Fund Provider |
J. Safra Sarasin Investmentfonds AG
Basel, Switzerland Phone: +41 58 317 44 44 Web: www.jsafrasarasin.com |
Fund Provider | J. Safra Sarasin Investmentfonds AG |
Representative in Switzerland | |
Distributor(s) |
Bank J. Safra Sarasin AG Basel Phone: +41 58 317 44 00 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The fund seeks long-term capital growth. It invests primarily in investment rights in Swiss securities of companies that contribute to a sustainable economic approach and other investments permitted under the Fund Agreement. These companies are distinguished by environmentally friendly, ecologically efficient management and for whom a proactive approach to relationships to the key stakeholders (e.g. employees, customers, donors, shareholders, the public authorities) is an important component of strategy. As a result, the Fund invests in the industry leaders who are utilizing the concept of sustainable development as a strategic opportunity. Individual industries may be excluded. Up to 20% of fund assets may be invested in bonds denominated in Swiss Francs (CHF). Furthermore, the Fund may also hold liquid assets in Swiss Francs (CHF). |
Peculiarities |
Current Price * | 105.85 CHF | 13.05.2025 |
---|---|---|
Previous Price * | 105.93 CHF | 12.05.2025 |
52 Week High * | 110.81 CHF | 03.03.2025 |
52 Week Low * | 92.73 CHF | 09.04.2025 |
NAV * | 105.85 CHF | 13.05.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 119,013,011 | |
Unit/Share Assets *** | 16,788,049 | |
Trading Information SIX |
YTD Performance | +6.31% |
30.12.2024 - 13.05.2025
30.12.2024 13.05.2025 |
---|---|---|
1 month | +7.89% |
14.04.2025 - 13.05.2025
14.04.2025 13.05.2025 |
3 months | -3.95% |
13.02.2025 - 13.05.2025
13.02.2025 13.05.2025 |
6 months | +4.22% |
13.11.2024 - 13.05.2025
13.11.2024 13.05.2025 |
1 year | -0.07% |
13.05.2024 - 13.05.2025
13.05.2024 13.05.2025 |
2 years | -0.23% |
15.05.2023 - 13.05.2025
15.05.2023 13.05.2025 |
3 years | +3.30% |
13.05.2022 - 13.05.2025
13.05.2022 13.05.2025 |
5 years | +14.70% |
08.01.2021 - 13.05.2025
08.01.2021 13.05.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Roche Holding AG | 13.77% | |
---|---|---|
Nestle SA | 13.52% | |
Novartis AG Registered Shares | 10.78% | |
UBS Group AG | 7.50% | |
Zurich Insurance Group AG | 7.09% | |
Compagnie Financiere Richemont SA Class A | 5.60% | |
ABB Ltd | 5.48% | |
Lonza Group Ltd | 4.31% | |
Sika AG | 4.01% | |
Partners Group Holding AG | 3.62% | |
Last data update | 28.02.2025 |
TER | 0.74% |
---|---|
TER date | 30.08.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.90% |
Ongoing Charges *** | 0.72% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |